Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
KRSNAA
Mr. Mitesh Dave · Pune, India
₹533.45
▬+0.04%KRSNAA is a mid-cap healthcare diagnostics company trading near its 52-week low with moderate valuation but facing revenue growth challenges.
Exchange
NSI
Currency
INR
Day range
₹531.30 – ₹540.55
52-week range
₹515.00 – ₹894.40
Sector
Healthcare
Industry
Diagnostics & Research
AI investment rating
AI analysis65% confidence
The stock appears moderately valued at 17.27x P/E but trading near its 52-week low, suggesting potential upside if growth improves, though current revenue growth of 3.5% YoY is uninspiring.
40.4% below the 1-year high · trend down
Hedge-fund memo
Today
Stock is flat today, trading near the lower end of its day range and 52-week low.
This week
No significant weekly movement observed, trading within recent range.
This month
The stock has declined from higher levels, currently down approximately 40% from its 52-week high.
Bull thesis
Bear thesis
Hidden risks
News & sentiment
Bullish
5 headlines · 3 outlets · 7d
scanx.trade·7d ago·more CT Scan sites
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 1 of 4 recent quarters (EPS actual vs. consensus).
12.7 vs 2.45
418.37% surprise
4.66 vs 6.06667
-23.19% surprise
7.25 vs 7.53333
-3.76% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| KRSNAA | 17.30B | 17.27 | 10.89% | 16.76% | 3.50% |
| VIJAYA | 141.31B | 81.42 | 19.70% | 32.45% | 26.60% |
| KIMS | 319.31B | 131.47 |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 500sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Slowing healthcare sector growth
Mitigation: Diversification into higher-margin specialized diagnostic services
High debt levels limiting operational flexibility
Mitigation: Focus on improving cash flows and reducing debt-to-equity ratio
Business intelligence
Competitive moat
The company benefits from established brand recognition in its operating regions and a network of diagnostic centers, though its moat appears modest compared to larger competitors.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
Expansion of diagnostic network in underserved markets
Introduction of new high-margin diagnostic tests
Thesis builder
Bull case
Improving diagnostic utilization rates and expansion into new service lines could drive 15-18% revenue growth over the next 2-3 years.
Base case
Stable but modest 8-10% revenue growth with margin expansion leading to 12-15% EPS growth annually.
Bear case
Continued slow growth and high leverage could constrain returns, potentially leading to flat performance.
Time horizon
12-18 months
Est. CAGR
8-15%
Entry (qual.)
Consider accumulating on dips below 500 INR with confirmation of growth acceleration.
Exit (qual.)
Scale above 750 INR as the stock approaches its previous high, especially without corresponding fundamental improvement.
Overall conviction 65%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how KRSNAA fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain KRSNAA for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden opportunities
Watch next
Hold with a wait-and-see approach for clearer growth trajectory before committing capital.
Whalesbook·7d ago·34 government institutions
Whalesbook·7d ago·34 government institutions CT Scan
Whalesbook·7d ago·34 government institutions new service
MarketsMojo·7d ago·technical momentum bearish
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
6.25 vs 7.08
-11.72% surprise
| 9.72% |
| 11.50% |
| 34.80% |
| WINDLAS | 17.72B | 27.55 | 12.23% | 7.25% | 17.70% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹531.30
Resistance (day/52w high)
₹540.55
Volume
48,015
Trend
down
RSI (14)
36
MACD
bearish
MA cross
death
50-day MA
₹544.88
200-day MA
₹648.65
vs 200-DMA
-17.8%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.